Alembic Pharmaceuticals informs about disclosure

06 May 2024 Evaluate

Alembic Pharmaceuticals has informed that the Company has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for the inspection carried out by them at our Oncology (Injectable and Oral Solid) Formulation Facility (F-2) at Panelav from 28th February, 2024 to 8th March, 2024. With this, for all its USFDA facilities, EIRs are in place.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

1039.90 1.70 (0.16%)
22-Nov-2024 11:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1771.00
Dr. Reddys Lab 1203.90
Cipla 1477.00
Lupin 2053.10
Zydus Lifesciences 942.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.